Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter,Open Label Crossover Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Pediatric Subjects With Epilepsy

Trial Profile

A Multicenter,Open Label Crossover Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Pediatric Subjects With Epilepsy

Recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Jan 2019

At a glance

  • Drugs Diazepam (Primary)
  • Indications Epilepsy
  • Focus Pharmacokinetics
  • Sponsors Aquestive Therapeutics
  • Most Recent Events

    • 10 Jan 2019 Planned End Date changed from 24 Nov 2018 to 24 Nov 2019.
    • 10 Jan 2019 Planned primary completion date changed from 30 Sep 2018 to 30 Sep 2019.
    • 12 Jul 2018 Planned End Date changed from 24 May 2018 to 24 Nov 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top